Related Experiment Videos
[Erythrocyte complement receptor (C3b) expression in multiple sclerosis]
Insights
Multiple sclerosis patients show a higher frequency of the low complement receptor (C3bR) phenotype on erythrocytes. This reduced expression appears linked to the disease process rather than solely genetic factors.
Area of Science:
- Immunology
- Genetics
- Neurology
Context:
- Multiple Sclerosis (MS) is a chronic autoimmune disease affecting the central nervous system.
- Complement receptors (C3bR) play a role in immune responses and are found on erythrocytes.
- Previous studies have explored genetic links in MS, but erythrocyte C3bR expression requires further investigation.
Purpose:
- To investigate the distribution of complement receptor (C3bR) phenotypes on erythrocytes in multiple sclerosis patients and healthy controls.
- To determine if genetic factors or the disease process itself influences C3bR expression in MS.
- To analyze family studies to understand the inheritance patterns of C3bR phenotypes in relation to MS.
Summary:
- A study involving 121 MS patients and 519 controls identified three C3bR phenotypes: high (HH), medium (HL), and low (LL).
- The low C3bR phenotype (C3bR1/C3bR1) was significantly more frequent in MS patients compared to controls.
- Family studies revealed discrepancies suggesting that reduced C3bR expression in MS is primarily influenced by the disease process, not solely by genetics.
Impact:
- Findings suggest that altered C3bR expression on erythrocytes is a potential biomarker or consequence of the MS disease process.
- This research opens avenues for understanding the immunopathology of MS and potential therapeutic targets.
- Highlights the complex interplay between genetic predisposition and disease activity in MS pathogenesis.
Abstract:
The study was carried out in 121 patients with multiple sclerosis and a control group of 519 healthy individuals. In 13 cases of multiple sclerosis and 12 controls family studies were carried out. Complement receptors (C3bR) on the erythrocytes were demonstrated by the haemagglutination test using human IgG heat-aggregated and guinea pig serum which served as a source of complement. On the basis of haemagglutination intensity and results of radioimmunoassay three phenotypes of complement receptor were isolated: high HH(C3bRh/C3bRh) producing strong agglutination, medium HL (C3bRh/Cbl) producing weak agglutination, and low phenotype LL (C3bR1/Cbl) in which no visible agglutination of erythrocytes was noted. Considerable differences were observed in the distribution of these phenotypes between controls and multiple sclerosis patients in whom the low phenotype (C3bR1/C3bR1) was more frequent. Family studies of controls suggested presence of two codominant alleles C3bRh and C3bR1 with Mendelian inheritance while similar studies of multiple sclerosis patients it was found that e.g. a child with multiple sclerosis whose parents had high C3bR phenotypes, that it were homozygotes for the C3bRh gene, had low phenotype. On the other hand, the high phenotype was found in a child of a female multiple sclerosis patient with the low phenotype (C3bR1/C3bR1). These observations suggest that reduced expression of the complement receptor on the erythrocytes depends in multiple sclerosis on the disease process in the first place, and not on genetic factors.